Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hepatitis

Free Subscription Articles published in J Viral Hepat Retrieve available abstracts of 222 articles: HTML format

Single Articles

July 2008
1. BRANT LJ , Hurrelle M, Balogun MA, Klapper P, et al
   Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. TOYODA H , Kumada T, Kiriyama S, Sone Y, et al
   Correlation of serum ribavirin concentration with pretreatment renal function estimates in patients with chronic hepatitis C receiving combination antiviral therapy with peginterferon and ribavirin.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. SCHERZER TM , Reddy KR, Wrba F, Hofer H, et al
   Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. SUTTON AJ , Edmunds WJ, Sweeting MJ, Gill ON, et al
   The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. BRANT LJ , Ramsay ME, Balogun MA, Boxall E, et al
   Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. BRUGGMANN P , Falcato L, Dober S, Helbling B, et al
   Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. WANG SH , Huang CX, Ye L, Wang X, et al
   Natural killer cells suppress full cycle HCV infection of human hepatocytes.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. MARTIN-CARBONERO L , Puoti M, Garcia-Samaniego J, De Luca A, et al
   Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. GAMBARIN-GELWAN M , Jacobson IM
   Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C.
   J Viral Hepat. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. ECHEVERRIA I , Zabaleta A, Silva L, Diaz-Valdes N, et al
    Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    June 2008
11. PARK JY , Park YN, Kim DY, Paik YH, et al
    High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. LUO K , Mao Q, Karayiannis P, Liu D, et al
    Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. VASSILOPOULOS D , Rapti I, Nikolaou M, Hadziyannis E, et al
    Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. POYNARD T , Munteanu M, Ngo Y, Moussalli J, et al
    FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence.
    J Viral Hepat. 2008;15:472-3.
    PubMed     Related articles   
    
    
    May 2008
15. TARANTINO G , Basile V, Conca P, Ariello M, et al
    Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved?
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. TSENG FC , Edlin BR, Zhang M, Kral A, et al
    The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. RONG Q , Zhang L, Su E, Li J, et al
    Bone marrow-derived mesenchymal stem cells are capable of mediating hepatitis B virus infection in injured tissues.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. TRINKS J , Cuestas ML, Tanaka Y, Mathet VL, et al
    Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. POUSTCHI H , Mohamadkhani A, Bowden S, Montazeri G, et al
    Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. WEILAND O , Hollander A, Mattsson L, Glaumann H, et al
    Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. CHOU R , Carson S, Chan BK
    Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. DERBALA MF , El Dweik NZ, Al Kaabi SR, Al-Marri AD, et al
    Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SCHIAVON LL , Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, et al
    Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. ZAMPINO R , Ingrosso D, Durante-Mangoni E, Capasso R, et al
    Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. CUEVAS JM , Torres-Puente M, Jimenez-Hernandez N, Bracho MA, et al
    Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. SHUDO E , Ribeiro RM, Perelson AS
    Modelling hepatitis C virus kinetics during treatment with pegylated interferon alpha-2b: errors in the estimation of viral kinetic parameters.
    J Viral Hepat. 2008;15:357-62.
    PubMed     Related articles    Abstract available
    
    
    April 2008
27. FABRIZI F , Ganeshan SV, Lunghi G, Messa P, et al
    Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. THOMSON EC , Main J
    Epidemiology of hepatitis C virus infection in HIV-infected individuals.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. NGUYEN TH , Jacobs P, Hanrahan A, Fraser-Lee N, et al
    Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. STRAUSS R , Torner A, Duberg AS, Hultcrantz R, et al
    Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. DUBERG AS , Torner A, Daviethsdottir L, Aleman S, et al
    Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. GAREN A
    Hepatitis RNA viruses and hepatocellular carcinoma.
    J Viral Hepat. 2008;.
    PubMed     Related articles   
    
    
    
33. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
    Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat. 2008;.
    PubMed     Related articles   
    
    
    
34. YURDAYDIN C , Bozkaya H, Onder FO, Senturk H, et al
    Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon.
    J Viral Hepat. 2008;15:314-21.
    PubMed     Related articles    Abstract available
    
    
    
35. KANG SM , Choi SH, Park CY, Kim MH, et al
    Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
    J Viral Hepat. 2008;15:305-13.
    PubMed     Related articles    Abstract available
    
    
    
36. NAPOLI N , Giannelli G, Antonaci A, Antonaci S, et al
    The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response.
    J Viral Hepat. 2008;15:300-4.
    PubMed     Related articles    Abstract available
    
    
    
37. NAKAMURA J , Toyabe SI, Aoyagi Y, Akazawa K, et al
    Economic impact of extended treatment with peginterferon alpha-2a and ribavirin for slow hepatitis C virologic responders.
    J Viral Hepat. 2008;15:293-9.
    PubMed     Related articles    Abstract available
    
    
    
38. YE L , Peng JS, Wang X, Wang YJ, et al
    Methamphetamine enhances Hepatitis C virus replication in human hepatocytes.
    J Viral Hepat. 2008;15:261-70.
    PubMed     Related articles    Abstract available
    
    
    
39. BANI-SADR F , Lapidus N, Melchior JC, Ravaux I, et al
    Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors.
    J Viral Hepat. 2008;15:255-60.
    PubMed     Related articles    Abstract available
    
    
    March 2008
40. MCHUTCHISON J , Sulkowski M
    Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. WARD CL , Dev A, Rigby S, Symonds WT, et al
    Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. FUJITA N , Sugimoto R, Ma N, Tanaka H, et al
    Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. BORTOLAMI M , Kotsafti A, Cardin R, Farinati F, et al
    Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. AGHEMO A , Rumi MG, Colombo M
    Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
    J Viral Hepat. 2008;.
    PubMed     Related articles   
    
    
    
45. LUM PJ , Hahn JA, Shafer KP, Evans JL, et al
    Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco.
    J Viral Hepat. 2008;15:229-36.
    PubMed     Related articles    Abstract available
    
    
    
46. CIESEK S , Liermann H, Hadem J, Greten T, et al
    Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    J Viral Hepat. 2008;15:200-11.
    PubMed     Related articles    Abstract available
    
    
    
47. TORRES-PUENTE M , Cuevas JM, Jimenez-Hernandez N, Bracho MA, et al
    Genetic variability in hepatitis C virus and its role in antiviral treatment response.
    J Viral Hepat. 2008;15:188-99.
    PubMed     Related articles    Abstract available
    
    
    
48. BRUCE MG , Bruden D, McMahon BJ, Christensen C, et al
    Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    J Viral Hepat. 2008;15:179-87.
    PubMed     Related articles    Abstract available
    
    
    
49. ZHANG XQ , Hong XJ, Bai XJ
    Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers.
    J Viral Hepat. 2008;15:173-8.
    PubMed     Related articles    Abstract available
    
    
    
50. CASTELLARES C , Barreiro P, Martin-Carbonero L, Labarga P, et al
    Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    J Viral Hepat. 2008;15:165-72.
    PubMed     Related articles    Abstract available
    
    
    February 2008
51. SHUDO E , Ribeiro RM, Perelson AS
    Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon alpha-2b.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. ZHU L , Tse CH, Wong VW, Chim AM, et al
    A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. TARANTINO G , Cabibi D, Camma C, Alessi N, et al
    Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. GIGI E , Raptopoulou-Gigi M, Kalogeridis A, Masiou S, et al
    Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    J Viral Hepat. 2008;15:145-54.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
55. VILLACRES MC , Literat O, Degiacomo M, Du W, et al
    Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.
    J Viral Hepat. 2008;15:137-44.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
56. REDDY KR , Govindarajan S, Marcellin P, Bernstein D, et al
    Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.
    J Viral Hepat. 2008;15:129-36.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
57. MOSLEY JW , Operskalski EA, Tobler LH, Buskell ZJ, et al
    The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
    J Viral Hepat. 2008;15:120-8.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
58. FRESHWATER DA , O'Donnell K, Mutimer DJ
    Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy.
    J Viral Hepat. 2008;15:115-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
59. LEEMANS WF , Janssen HL, Niesters HG, de Man RA, et al
    Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
    J Viral Hepat. 2008;15:108-14.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
60. VIVEKANANDAN P , Thomas D, Torbenson M
    Hepatitis B viral DNA is methylated in liver tissues.
    J Viral Hepat. 2008;15:103-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
61. KATZ LH , Fraser A, Gafter-Gvili A, Leibovici L, et al
    Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.
    J Viral Hepat. 2008;15:89-102.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
62. FABRIZI F , Dixit V, Messa P, Martin P, et al
    Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    J Viral Hepat. 2008;15:79-88.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
63. BOUSTIERE CH , Napoleon B, Delasalle P, Coulom P, et al
    Digestive endoscopies are not a risk factor for transmission of virus C.
    J Viral Hepat. 2008;15:155.
    PubMed     Related articles   
    
    
    January 2008
64. BIASIOLO A , Chemello L, Quarta S, Cavalletto L, et al
    Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. MATHEI C , Van Dooren S, Lemey P, Van Damme P, et al
    The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. YU H , Babiuk LA, van Drunen Littel-van den Hurk S
    Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
67. SHEA DO , Tuite H, Farrell G, Codd M, et al
    Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. HAMED MR , Tarr AW, McClure CP, Ball JK, et al
    Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. LOGGI E , Gramenzi A, Margotti M, Cursaro C, et al
    In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. DE LEDINGHEN V , Barreiro P, Foucher J, Labarga P, et al
    Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. RUYS TA , Nanlohy NM, van den Berg CH, Hassink E, et al
    HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. GALLEGO A , Sheldon J, Garcia-Samaniego J, Margall N, et al
    Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. CHANG WW , Su IJ, Lai MD, Chang WT, et al
    Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxide.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. DE P , Roy E, Boivin JF, Cox J, et al
    Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
75. BLACKARD JT , Sherman KE
    HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. MANN AG , Trotter CL, Adekoyejo Balogun M, Ramsay ME, et al
    Hepatitis C in ethnic minority populations in England.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. BARNES E , Salio M, Cerundolo V, Francesco L, et al
    Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
78. YOUNOSSI ZM , Nader FH, Bai C, Sjogren R, et al
    A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. PAPATHEODORIDIS GV , Chrysanthos N, Hadziyannis E, Cholongitas E, et al
    Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    J Viral Hepat. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
80. SCHOTT E , Witt H, Neumann K, Bergk A, et al
    Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.
    J Viral Hepat. 2008;15:71-8.
    PubMed     Related articles    Abstract available
    
    
    
81. FERRARO D , Giglio M, Bonura C, Di Marco V, et al
    Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay.
    J Viral Hepat. 2008;15:66-70.
    PubMed     Related articles    Abstract available
    
    
    
82. HUNG CH , Chen CH, Lee CM, Wu CM, et al
    Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.
    J Viral Hepat. 2008;15:58-65.
    PubMed     Related articles    Abstract available
    
    
    
83. POWIS J , Peltekian KM, Lee SS, Sherman M, et al
    Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
    J Viral Hepat. 2008;15:52-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
84. HANN HW , Han SH, Block TM, Harris M, et al
    Symptomatology and health attitudes of chronic hepatitis B patients in the USA.
    J Viral Hepat. 2008;15:42-51.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
85. TER BORG MJ , Leemans WF, de Man RA, Janssen HL, et al
    Exacerbation of chronic hepatitis B infection after delivery.
    J Viral Hepat. 2008;15:37-41.
    PubMed     Related articles    Abstract available
    
    
    
86. ULCICKAS YOOD M , Quesenberry CP Jr, Guo D, Wells K, et al
    Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm.
    J Viral Hepat. 2008;15:28-36.
    PubMed     Related articles    Abstract available
    
    
    
87. JONAS MM , Little NR, Gardner SD
    Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
    J Viral Hepat. 2008;15:20-27.
    PubMed     Related articles    Abstract available
    
    
    
88. SU FH , Chen JD, Cheng SH, Sung KY, et al
    Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    J Viral Hepat. 2008;15:14-9.
    PubMed     Related articles    Abstract available
    
    
    
89. COHEN C , Evans AA, London WT, Block J, et al
    Underestimation of chronic hepatitis B virus infection in the United States of America.
    J Viral Hepat. 2008;15:12-3.
    PubMed     Related articles       Free Full Text
    
    
    
90. DEUTSCH M , Hadziyannis SJ
    Old and emerging therapies in chronic hepatitis C: an update.
    J Viral Hepat. 2008;15:2-11.
    PubMed     Related articles    Abstract available
    
    
    December 2007
91. SEBASTIANI G , Vario A, Guido M, Alberti A, et al
    Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. NUNEZ M , Ocampo A, Aguirrebengoa K, Cervantes M, et al
    Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. PEREZ-BERNA AJ , Veiga AS, Castanho MA, Villalain J, et al
    Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. GONZALEZ SA , Zhang C, Fiel MI, Chung S, et al
    Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. LINDH M , Hellstrand K, Norkrans G
    Wider indications for treatment of chronic hepatitis B?
    J Viral Hepat. 2007;.
    PubMed     Related articles   
    
    
    
96. ROINGEARD P , Hourioux C
    Hepatitis C virus core protein, lipid droplets and steatosis.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. ZAAIJER HL , Bouter S, Boot HJ
    Substitution rate of the hepatitis B virus surface gene.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. ANTAKI N , Hermes A, Hadad M, Ftayeh M, et al
    Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. HICKMAN M , McDonald T, Judd A, Nichols T, et al
    Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial.
    J Viral Hepat. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. THOMSON BJ , Kwong G, Ratib S, Sweeting M, et al
     Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.
     J Viral Hepat. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. BUTT AA , Khan UA, McGinnis KA, Skanderson M, et al
     Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans.
     J Viral Hepat. 2007;14:890-6.
     PubMed     Related articles    Abstract available
     
     
     
102. ROWAN PJ , Dunn NJ, El-Serag HB, Kunik ME, et al
     Views of hepatitis C virus patients delayed from treatment for psychiatric reasons.
     J Viral Hepat. 2007;14:883-9.
     PubMed     Related articles    Abstract available
     
     
     
103. TALIANI G , Rucci P, Biliotti E, Cirrincione L, et al
     Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:875-882.
     PubMed     Related articles    Abstract available
     
     
     
104. PALMATEER NE , Hutchinson SJ, McLeod A, Codere G, et al
     Comparison of deaths related to Hepatitis C and AIDS in Scotland.
     J Viral Hepat. 2007;14:870-4.
     PubMed     Related articles    Abstract available
     
     
     
105. BERENGUER J , Bellon JM, Miralles P, Alvarez E, et al
     Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.
     J Viral Hepat. 2007;14:859-69.
     PubMed     Related articles    Abstract available
     
     
     
106. ZHOU Y , Lukes Y, Anderson J, Fileta B, et al
     Hepatitis C virus E2 envelope protein induces dendritic cell maturation.
     J Viral Hepat. 2007;14:849-58.
     PubMed     Related articles    Abstract available
     
     
     
107. KUMMEE P , Tangkijvanich P, Poovorawan Y, Hirankarn N, et al
     Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
     J Viral Hepat. 2007;14:841-8.
     PubMed     Related articles    Abstract available
     
     
     
108. JARDI R , Rodriguez-Frias F, Schaper M, Ruiz G, et al
     Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients.
     J Viral Hepat. 2007;14:835-40.
     PubMed     Related articles    Abstract available
     
     
     
109. KAYA D , Guler E, Ekerbicer HC, Dilber C, et al
     Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey.
     J Viral Hepat. 2007;14:830-4.
     PubMed     Related articles    Abstract available
     
     
     
110. FARINATI F , Cardin R, Bortolami M, Burra P, et al
     Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
     J Viral Hepat. 2007;14:821-9.
     PubMed     Related articles    Abstract available
     
     
     November 2007
111. EISENBACH C , Neumann-Haefelin C, Freyse A, Korsukewitz T, et al
     Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus.
     J Viral Hepat. 2007;14:817-9.
     PubMed     Related articles   
     
     
     
112. YURDAYDIN C , Bozkaya H, Karaaslan H, Onder FO, et al
     A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.
     J Viral Hepat. 2007;14:812-816.
     PubMed     Related articles    Abstract available
     
     
     
113. BONNARD P , Lescure FX, Amiel C, Guiard-Schmid JB, et al
     Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
     J Viral Hepat. 2007;14:806-11.
     PubMed     Related articles    Abstract available
     
     
     
114. YEUNG LT , To T, King SM, Roberts EA, et al
     Spontaneous clearance of childhood hepatitis C virus infection.
     J Viral Hepat. 2007;14:797-805.
     PubMed     Related articles    Abstract available
     
     
     
115. WITTHOFT T , Moller B, Wiedmann KH, Mauss S, et al
     Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial.
     J Viral Hepat. 2007;14:788-96.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
116. KOIRALA J , Gandotra SD, Rao S, Sangwan G, et al
     Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.
     J Viral Hepat. 2007;14:782-7.
     PubMed     Related articles    Abstract available
     
     
     
117. JESSNER W , Watkins-Riedel T, Muller C, Formann E, et al
     Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
     J Viral Hepat. 2007;14:775-81.
     PubMed     Related articles    Abstract available
     
     
     
118. PAN XP , Li LJ, Du WB, Li MW, et al
     Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
     J Viral Hepat. 2007;14:767-74.
     PubMed     Related articles    Abstract available
     
     
     
119. LACEY LF , Gane E
     The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.
     J Viral Hepat. 2007;14:751-66.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
120. INCHAUSPE G , Michel ML
     Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
     J Viral Hepat. 2007;14 Suppl 1:97-103.
     PubMed     Related articles    Abstract available
     
     
     
121. ROCHE B , Samuel D
     Risk factors for hepatitis C recurrence after liver transplantation.
     J Viral Hepat. 2007;14 Suppl 1:89-96.
     PubMed     Related articles    Abstract available
     
     
     
122. HEATHCOTE EJ
     Antiviral therapy: chronic hepatitis C.
     J Viral Hepat. 2007;14 Suppl 1:82-8.
     PubMed     Related articles    Abstract available
     
     
     
123. CHEVALIEZ S , Pawlotsky JM
     Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
     J Viral Hepat. 2007;14 Suppl 1:77-81.
     PubMed     Related articles    Abstract available
     
     
     
124. DREUX M , Cosset FL
     The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies.
     J Viral Hepat. 2007;14 Suppl 1:68-76.
     PubMed     Related articles    Abstract available
     
     
     
125. BRASS V , Moradpour D, Blum HE
     Hepatitis C virus infection: in vivo and in vitro models.
     J Viral Hepat. 2007;14 Suppl 1:64-7.
     PubMed     Related articles    Abstract available
     
     
     
126. FARCI P , Chessa L, Balestrieri C, Serra G, et al
     Treatment of chronic hepatitis D.
     J Viral Hepat. 2007;14 Suppl 1:58-63.
     PubMed     Related articles    Abstract available
     
     
     
127. ROGGENDORF M , Schulte I, Xu Y, Lu M, et al
     Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
     J Viral Hepat. 2007;14 Suppl 1:51-7.
     PubMed     Related articles    Abstract available
     
     
     
128. BOHNE F , Protzer U
     Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B.
     J Viral Hepat. 2007;14 Suppl 1:45-50.
     PubMed     Related articles    Abstract available
     
     
     
129. COFFIN CS , Terrault NA
     Management of hepatitis B in liver transplant recipients.
     J Viral Hepat. 2007;14 Suppl 1:37-44.
     PubMed     Related articles    Abstract available
     
     
     
130. ZOULIM F , Buti M, Lok AS
     Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
     J Viral Hepat. 2007;14 Suppl 1:29-36.
     PubMed     Related articles    Abstract available
     
     
     
131. GERLICH WH , Glebe D, Schuttler CG
     Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus.
     J Viral Hepat. 2007;14 Suppl 1:16-21.
     PubMed     Related articles    Abstract available
     
     
     
132. HOLLINGER FB
     Hepatitis B virus genetic diversity and its impact on diagnostic assays.
     J Viral Hepat. 2007;14 Suppl 1:11-5.
     PubMed     Related articles    Abstract available
     
     
     
133. LAI CL , Yuen MF
     The natural history of chronic hepatitis B.
     J Viral Hepat. 2007;14 Suppl 1:6-10.
     PubMed     Related articles    Abstract available
     
     
     
134. BLAINE HOLLINGER F , Bell B, Levy-Bruhl D, Shouval D, et al
     Hepatitis A and B vaccination and public health.
     J Viral Hepat. 2007;14 Suppl 1:1-5.
     PubMed     Related articles    Abstract available
     
     
     
135. 
     Proceedings of the 12th International Symposium on Viral Hepatitis and Liver Disease. July 1-5, 2006. Paris, France.
     J Viral Hepat. 2007;14 Suppl 1:1-103.
     PubMed     Related articles   
     
     
     
136. MASON WS , Litwin S, Xu C, Jilbert AR, et al
     Hepatocyte turnover in transient and chronic hepadnavirus infections.
     J Viral Hepat. 2007;14 Suppl 1:22-8.
     PubMed     Related articles    Abstract available
     
     
     October 2007
137. SPRENGERS D , van der Molen RG, Binda R, Kusters JG, et al
     In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection.
     J Viral Hepat. 2007;14:743-9.
     PubMed     Related articles    Abstract available
     
     
     
138. RAMOS-CASALS M , Forns X, Brito-Zeron P, Vargas A, et al
     Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.
     J Viral Hepat. 2007;14:736-42.
     PubMed     Related articles    Abstract available
     
     
     
139. BENET T , D'Oliveira A Jr, Voirin N, Livrozet JM, et al
     Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.
     J Viral Hepat. 2007;14:730-735.
     PubMed     Related articles    Abstract available
     
     
     
140. DI BISCEGLIE AM , Ghalib RH, Hamzeh FM, Rustgi VK, et al
     Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
     J Viral Hepat. 2007;14:721-9.
     PubMed     Related articles    Abstract available
     
     
     
141. MASARONE M , La Mura V, Bruno S, Gaeta GB, et al
     Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
     J Viral Hepat. 2007;14:714-20.
     PubMed     Related articles    Abstract available
     
     
     
142. TURAL C , Sola R, Rubio R, Santin M, et al
     Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
     J Viral Hepat. 2007;14:704-13.
     PubMed     Related articles    Abstract available
     
     
     
143. FABRIZI F , Takkouche B, Lunghi G, Dixit V, et al
     The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
     J Viral Hepat. 2007;14:697-703.
     PubMed     Related articles    Abstract available
     
     
     
144. BUTT AA , Skanderson M, McGinnis KA, Ahuja T, et al
     Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.
     J Viral Hepat. 2007;14:688-96.
     PubMed     Related articles    Abstract available
     
     
     
145. ZEREMSKI M , Petrovic LM, Talal AH
     The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:675-87.
     PubMed     Related articles    Abstract available
     
     
     September 2007
146. KURBANOV F , Tanaka Y, Elkady A, Oyunsuren T, et al
     Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
     J Viral Hepat. 2007;14:667-74.
     PubMed     Related articles    Abstract available
     
     
     
147. FUKAI K , Zhang KY, Imazeki F, Kurihara T, et al
     Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
     J Viral Hepat. 2007;14:661-6.
     PubMed     Related articles    Abstract available
     
     
     
148. HOPE VD , Ncube F, Hickman M, Judd A, et al
     Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
     J Viral Hepat. 2007;14:653-60.
     PubMed     Related articles    Abstract available
     
     
     
149. HICKMAN M , Hope V, Brady T, Madden P, et al
     Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.
     J Viral Hepat. 2007;14:645-52.
     PubMed     Related articles    Abstract available
     
     
     
150. BANI-SADR F , Goderel I, Penalba C, Billaud E, et al
     Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
     J Viral Hepat. 2007;14:639-644.
     PubMed     Related articles    Abstract available
     
     
     
151. SAGIR A , Heintges T, Akyazi Z, Oette M, et al
     Therapy outcome in patients with chronic hepatitis C: role of therapy supervision by expert hepatologists.
     J Viral Hepat. 2007;14:633-8.
     PubMed     Related articles    Abstract available
     
     
     
152. RICHMOND JA , Dunning TL, Desmond PV
     Health professionals' attitudes toward caring for people with hepatitis C.
     J Viral Hepat. 2007;14:624-32.
     PubMed     Related articles    Abstract available
     
     
     
153. STROFFOLINI T , Sagnelli E, Mele A, Cottone C, et al
     HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
     J Viral Hepat. 2007;14:618-623.
     PubMed     Related articles    Abstract available
     
     
     
154. TRUJILLO-MURILLO K , Alvarez-Martinez O, Garza-Rodriguez L, Martinez-Rodriguez H, et al
     Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
     J Viral Hepat. 2007;14:608-17.
     PubMed     Related articles    Abstract available
     
     
     
155. YONEDA M , Saito S, Ikeda T, Fujita K, et al
     Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
     J Viral Hepat. 2007;14:600-7.
     PubMed     Related articles    Abstract available
     
     
     August 2007
156. SCHUMANN A , Fiedler M, Dahmen U, Grosse-Wilde H, et al
     Cellular and humoral immune response to a third generation hepatitis B vaccine.
     J Viral Hepat. 2007;14:592-8.
     PubMed     Related articles    Abstract available
     
     
     
157. JUDD A , Hickman M, Hope VD, Sutton AJ, et al
     Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
     J Viral Hepat. 2007;14:584-91.
     PubMed     Related articles    Abstract available
     
     
     
158. SIAGRIS D , Vafiadis G, Michalaki M, Lekkou A, et al
     Serum adiponectin in chronic hepatitis C and B.
     J Viral Hepat. 2007;14:577-83.
     PubMed     Related articles    Abstract available
     
     
     
159. SWEETING MJ , De Angelis D, Brant LJ, Harris HE, et al
     The burden of hepatitis C in England.
     J Viral Hepat. 2007;14:570-6.
     PubMed     Related articles    Abstract available
     
     
     
160. WEBSTER D , Ahmed R, Tandon P, Chui L, et al
     Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:564-9.
     PubMed     Related articles    Abstract available
     
     
     
161. PRADAT P , Tillmann HL, Sauleda S, Braconier JH, et al
     Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
     J Viral Hepat. 2007;14:556-63.
     PubMed     Related articles    Abstract available
     
     
     
162. FRANCESCHINI B , Russo C, Dioguardi N, Grizzi F, et al
     Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.
     J Viral Hepat. 2007;14:549-55.
     PubMed     Related articles    Abstract available
     
     
     
163. PHAM TN , Mulrooney-Cousins PM, Mercer SE, Macparland SA, et al
     Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.
     J Viral Hepat. 2007;14:537-48.
     PubMed     Related articles    Abstract available
     
     
     
164. GERKENS S , Nechelput M, Annemans L, Peraux B, et al
     A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C.
     J Viral Hepat. 2007;14:523-36.
     PubMed     Related articles    Abstract available
     
     
     July 2007
165. WEN WH , Qin WJ, Gao H, Zhao J, et al
     An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells.
     J Viral Hepat. 2007;14:512-9.
     PubMed     Related articles    Abstract available
     
     
     
166. LIN CY , Tsai MC, Huang CT, Hsu CW, et al
     Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B.
     J Viral Hepat. 2007;14:503-11.
     PubMed     Related articles    Abstract available
     
     
     
167. SEMMO N , Krashias G, Willberg C, Klenerman P, et al
     Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
     J Viral Hepat. 2007;14:492-502.
     PubMed     Related articles    Abstract available
     
     
     
168. HOFMANN WP , Fernandez B, Herrmann E, Welsch C, et al
     Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
     J Viral Hepat. 2007;14:484-91.
     PubMed     Related articles    Abstract available
     
     
     
169. KNOLL A , Boehm S, Hahn J, Holler E, et al
     Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
     J Viral Hepat. 2007;14:478-83.
     PubMed     Related articles    Abstract available
     
     
     
170. ZEKRI AR , Haleem HA, Esmat GE, Bahnassy AA, et al
     Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.
     J Viral Hepat. 2007;14:468-77.
     PubMed     Related articles    Abstract available
     
     
     
171. ROULOT D , Bourcier V, Grando V, Deny P, et al
     Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
     J Viral Hepat. 2007;14:460-7.
     PubMed     Related articles    Abstract available
     
     
     
172. ARBUTHNOT P , Longshaw V, Naidoo T, Weinberg MS, et al
     Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
     J Viral Hepat. 2007;14:447-59.
     PubMed     Related articles    Abstract available
     
     
     
173. HE YL , Zhao YR, Zhang SL, Lin SM, et al
     Defects in the apoptotic machinery are associated with hepatic damage.
     J Viral Hepat. 2007;14:520-2.
     PubMed     Related articles   
     
     
     June 2007
174. WANG Z , Hou J, Zeng G, Wen S, et al
     Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China*.
     J Viral Hepat. 2007;14:426-34.
     PubMed     Related articles    Abstract available
     
     
     
175. LUO K , He H, Liu Z, Zhu Y, et al
     No significant differences in histology and response to interferon treatment in hepatitis B carriers of genotypes C and recombinant B.
     J Viral Hepat. 2007;14:419-25.
     PubMed     Related articles    Abstract available
     
     
     
176. MICALLEF JM , Macdonald V, Jauncey M, Amin J, et al
     High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
     J Viral Hepat. 2007;14:413-8.
     PubMed     Related articles    Abstract available
     
     
     
177. MIYATAKE H , Kanto T, Inoue M, Sakakibara M, et al
     Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
     J Viral Hepat. 2007;14:404-12.
     PubMed     Related articles    Abstract available
     
     
     
178. ASAHINA Y , Izumi N, Umeda N, Hosokawa T, et al
     Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
     J Viral Hepat. 2007;14:396-403.
     PubMed     Related articles    Abstract available
     
     
     
179. MARTIN-CARBONERO L , Barreiro P, Jimenez-Galan G, Garcia-Berriguete R, et al
     Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
     J Viral Hepat. 2007;14:392-5.
     PubMed     Related articles    Abstract available
     
     
     
180. RAMOS B , Nunez M, Rendon A, Berdun MA, et al
     Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
     J Viral Hepat. 2007;14:387-91.
     PubMed     Related articles    Abstract available
     
     
     
181. SULKOWSKI MS , Benhamou Y
     Therapeutic issues in HIV/HCV-coinfected patients.
     J Viral Hepat. 2007;14:371-86.
     PubMed     Related articles    Abstract available
     
     
     
182. ARANKALLE VA , Lole KS, Deshmukh TM, Chobe LP, et al
     Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections.
     J Viral Hepat. 2007;14:435-45.
     PubMed     Related articles    Abstract available
     
     
     May 2007
183. MORIONDO M , Resti M, Betti L, Indolfi G, et al
     SEN virus co-infection among HCV-RNA-positive mothers, risk of transmission to the offspring and outcome of child infection during a 1-year follow-up.
     J Viral Hepat. 2007;14:355-9.
     PubMed     Related articles    Abstract available
     
     
     
184. BUSTER EH , van der Eijk AA, de Man RA, Janssen HL, et al
     Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.
     J Viral Hepat. 2007;14:350-4.
     PubMed     Related articles    Abstract available
     
     
     
185. WELKER MW , Hofmann WP, Welsch C, von Wagner M, et al
     Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients.
     J Viral Hepat. 2007;14:338-49.
     PubMed     Related articles    Abstract available
     
     
     
186. TIMM J , Neukamm M, Kuntzen T, Kim AY, et al
     Characterization of full-length hepatitis C virus genotype 4 sequences.
     J Viral Hepat. 2007;14:330-7.
     PubMed     Related articles    Abstract available
     
     
     
187. PILLAI V , Lee WM, Thiele DL, Karandikar NJ, et al
     Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.
     J Viral Hepat. 2007;14:318-29.
     PubMed     Related articles    Abstract available
     
     
     
188. SHUKLA P , Chauhan UK, Naik S, Anderson D, et al
     Hepatitis E virus infection among animals in northern India: an unlikely source of human disease.
     J Viral Hepat. 2007;14:310-7.
     PubMed     Related articles    Abstract available
     
     
     
189. DALTON HR , Thurairajah PH, Fellows HJ, Hussaini HS, et al
     Autochthonous hepatitis E in southwest England.
     J Viral Hepat. 2007;14:304-9.
     PubMed     Related articles    Abstract available
     
     
     
190. PERON JM , Bureau C, Poirson H, Mansuy JM, et al
     Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.
     J Viral Hepat. 2007;14:298-303.
     PubMed     Related articles    Abstract available
     
     
     
191. TEO CG
     The two clinico-epidemiological forms of hepatitis E.
     J Viral Hepat. 2007;14:295-7.
     PubMed     Related articles   
     
     
     
192. COCO B , Oliveri F, Maina AM, Ciccorossi P, et al
     Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
     J Viral Hepat. 2007;14:360-9.
     PubMed     Related articles    Abstract available
     
     
     April 2007
193. RUIZ-FERRER M , Antinolo G, Aguilar-Reina J
     Analysis of the -844C > T polymorphism in the promoter region of FASLgene in a cohort of Spanish HCV patients.
     J Viral Hepat. 2007;14:293-4.
     PubMed     Related articles   
     
     
     
194. AGGARWAL R , Shukla R, Jameel S, Agrawal S, et al
     T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.
     J Viral Hepat. 2007;14:283-92.
     PubMed     Related articles    Abstract available
     
     
     
195. YUEN MF , Wong DK, Zheng BJ, Chan CC, et al
     Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
     J Viral Hepat. 2007;14:269-75.
     PubMed     Related articles    Abstract available
     
     
     
196. KAFATOS G , Anastassopoulou C, Nardone A, Andrews N, et al
     The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus.
     J Viral Hepat. 2007;14:260-8.
     PubMed     Related articles    Abstract available
     
     
     
197. GOULDING C , O'brien C, Egan H, Hegarty JE, et al
     The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source.
     J Viral Hepat. 2007;14:255-9.
     PubMed     Related articles    Abstract available
     
     
     
198. JAYARAMAN GC , Lee B, Singh AE, Preiksaitis JK, et al
     Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001).
     J Viral Hepat. 2007;14:249-54.
     PubMed     Related articles    Abstract available
     
     
     
199. SHIRE NJ , Welge JA, Sherman KE
     Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis.
     J Viral Hepat. 2007;14:239-48.
     PubMed     Related articles    Abstract available
     
     
     
200. CRESPO M , Sauleda S, Esteban JI, Juarez A, et al
     Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
     J Viral Hepat. 2007;14:228-38.
     PubMed     Related articles    Abstract available
     
     
     
201. MANGIA A
     Short-duration therapy for hepatitis C: suitable for all?
     J Viral Hepat. 2007;14:221-227.
     PubMed     Related articles    Abstract available
     
     
     
202. WANG K , Fan X, Fan Y, Wang B, et al
     Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
     J Viral Hepat. 2007;14:276-82.
     PubMed     Related articles    Abstract available
     
     
     March 2007
203. HARRIS HE , Eldridge KP, Harbour S, Alexander G, et al
     Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?
     J Viral Hepat. 2007;14:213-20.
     PubMed     Related articles    Abstract available
     
     
     
204. SMITH RM , Smolic R, Volarevic M, Wu GY, et al
     Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
     J Viral Hepat. 2007;14:194-212.
     PubMed     Related articles    Abstract available
     
     
     
205. OVERTON ET , Nurutdinova D, Sungkanuparph S, Seyfried W, et al
     Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
     J Viral Hepat. 2007;14:189-93.
     PubMed     Related articles    Abstract available
     
     
     
206. JAIN MK , Comanor L, White C, Kipnis P, et al
     Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
     J Viral Hepat. 2007;14:176-82.
     PubMed     Related articles    Abstract available
     
     
     
207. JANG JW , Lee YC, Kim MS, Lee SY, et al
     A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
     J Viral Hepat. 2007;14:169-75.
     PubMed     Related articles    Abstract available
     
     
     
208. CHOI MS , Kim DY, Lee DH, Lee JH, et al
     Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
     J Viral Hepat. 2007;14:161-8.
     PubMed     Related articles    Abstract available
     
     
     
209. TSAI FC , Liu CJ, Chen CL, Chen PJ, et al
     Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
     J Viral Hepat. 2007;14:153-60.
     PubMed     Related articles    Abstract available
     
     
     
210. CHU CM , Liaw YF
     Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.
     J Viral Hepat. 2007;14:147-52.
     PubMed     Related articles    Abstract available
     
     
     
211. ROSENTHAL E , Pialoux G, Bernard N, Pradier C, et al
     Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAV